{"gene":"PDX1","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1996,"finding":"PDX-1 (pdx-1) null mutation in mice results in failure of pancreatic bud outgrowth beyond initial formation; the dorsal bud forms but undergoes only limited proliferation without insulin or amylase-positive cells, demonstrating PDX-1 is required for pancreatic progenitor proliferation and differentiation. Additionally, the rostral duodenum shows loss of normal columnar epithelium replaced by GLUT2-positive cuboidal epithelium.","method":"Gene targeting / knockout mouse (two independent null alleles including lacZ knock-in), histology, immunostaining","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — two independent null alleles with rigorous histological analysis, replicated finding of pancreatic agenesis","pmids":["8631275"],"is_preprint":false},{"year":1994,"finding":"IDX-1 (PDX1) binds to three sites in the 5' flanking region of the rat somatostatin gene and transactivates somatostatin promoter-reporter constructs; mutation of IDX-1 binding sites attenuates transactivation, identifying somatostatin as a direct transcriptional target.","method":"Electrophoretic mobility shift assay (EMSA), co-transfection reporter assay with promoter mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding assay combined with mutagenesis and reporter assay, foundational paper replicated by subsequent studies","pmids":["7907546"],"is_preprint":false},{"year":1996,"finding":"PDX-1 binds to a conserved TAAT motif (GLUT2TAAT) in the murine and human GLUT2 promoter and transactivates GLUT2 gene expression; mutation of the GLUT2TAAT motif reduces promoter activity by 41%, and PDX-1 activates a heterologous promoter containing multimerized GLUT2TAAT only in PDX-1-expressing cell lines.","method":"EMSA, co-transfection reporter assay with promoter mutants, supershift with PDX-1 antiserum","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct binding demonstrated by EMSA with antibody supershift, functional consequence confirmed by mutagenesis and reporter assay","pmids":["8923459"],"is_preprint":false},{"year":1995,"finding":"STF-1/PDX-1 binds cooperatively with Pbx (mammalian homolog of extradenticle) to DNA; cooperative binding requires the pentapeptide FPWMK motif and the N-terminal arm of the STF-1 homeodomain. Cooperative binding occurs only on a subset of potential STF-1 target sites, suggesting Pbx specifies target gene selection.","method":"EMSA with recombinant proteins and mutagenesis of FPWMK motif and homeodomain","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted cooperative DNA binding in vitro with domain mutagenesis identifying key residues","pmids":["8524276"],"is_preprint":false},{"year":1996,"finding":"STF-1 (PDX1) islet-specific expression requires two elements: a distal enhancer (-3 to -6.5 kb) and a proximal E-box at -104 bound by the helix-loop-helix/leucine zipper factor USF; point mutation disrupting USF binding impairs STF-1 promoter activity in transgenic mice.","method":"Transgenic reporter assay, mutagenesis, EMSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis validated in transgenic mice combined with direct binding assay","pmids":["8567692"],"is_preprint":false},{"year":1997,"finding":"An islet-specific enhancer directing STF-1 (PDX1) expression is regulated by HNF-3beta and BETA-2 binding elements; glucocorticoids repress STF-1 gene expression by interfering with HNF-3beta activity on this enhancer, and overexpression of HNF-3beta suppresses glucocorticoid receptor-mediated inhibition.","method":"Reporter assay, overexpression, glucocorticoid receptor inhibition","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assay with overexpression, single lab with two orthogonal approaches","pmids":["9111329"],"is_preprint":false},{"year":1996,"finding":"Domain mapping of IDX-1 (PDX1) identifies: the homeodomain mediates sequence-specific DNA binding (substitution mutations abolish binding); the N-terminal transactivation domain is required for somatostatin promoter transactivation; C-terminal regions mediate protein-protein interactions that synergistically enhance transactivation; nuclear localization signals reside within the homeodomain.","method":"N- and C-terminal deletion and point-substitution mutagenesis, EMSA, reporter assay, nuclear extract fractionation","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis with multiple orthogonal methods (DNA binding, nuclear localization, reporter assay) in one study","pmids":["8770920"],"is_preprint":false},{"year":1997,"finding":"Exposure of isolated rat pancreatic islets to palmitic acid causes ~70% decrease in IDX-1 mRNA and protein and 40-65% decreases in IDX-1 binding activity at Glut2 and insulin promoter elements, correlating with decreases in GLUT2, glucokinase, insulin, and somatostatin expression; this effect requires mitochondrial oxidation of palmitate (prevented by carnitine palmitoyltransferase I inhibitor).","method":"Western blot, EMSA, RT-PCR, pharmacological inhibition of mitochondrial fatty acid oxidation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (protein, mRNA, DNA binding activity) replicated in primary islets with mechanistic inhibitor","pmids":["9374511"],"is_preprint":false},{"year":1998,"finding":"STF-1/PDX-1 expression decreases rapidly and reversibly in INS-1 cells exposed to elevated glucose (>8 mM); the decrease in STF-1 binding activity correlates with decreased STF-1 mRNA occurring independently of changes in STF-1 promoter activity, suggesting posttranscriptional regulation; associated insulin gene promoter activity decreases are partially reversed by lowering glucose.","method":"Transient transfection reporter assay, EMSA, Northern blot, RT-PCR","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (reporter assay, EMSA, mRNA levels) in single lab","pmids":["9482663"],"is_preprint":false},{"year":1998,"finding":"Misexpressed IDX-1 (PDX1) binds to and inhibits transactivation of the sucrase-isomaltase promoter by the gut homeodomain protein Cdx-2, providing a mechanism for the dysmorphogenesis of the proximal colon observed in Hoxa-4/IDX-1 transgenic mice.","method":"Transgenic mouse model, reporter assay, protein-protein interaction analysis","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional interaction between PDX-1 and Cdx-2 demonstrated by reporter assay and binding analysis in transgenic model","pmids":["9679043"],"is_preprint":false},{"year":2004,"finding":"PDX-1 directly binds to the GIP gene promoter regulatory region in intact cells and nuclear extracts, and overexpression of PDX-1 in transfection assays increases GIP/luciferase reporter activity; PDX-1 null mice show 97.8% reduction in GIP-expressing cells, establishing PDX-1 as a direct regulator of cell-specific GIP expression.","method":"EMSA, chromatin immunoprecipitation (ChIP), transient transfection reporter assay, PDX-1 null mouse analysis","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct chromatin occupancy by ChIP confirmed in intact cells, combined with null mouse phenotype and reporter assay","pmids":["15486225"],"is_preprint":false},{"year":2004,"finding":"PCIF1 (a POZ domain protein) interacts with the C-terminus of PDX-1 both in vitro and in vivo; coexpression of PDX-1 alters subnuclear distribution of PCIF1; PCIF1 inhibits PDX-1 transactivation of target gene promoters in a dose-dependent manner requiring critical amino acids in the PDX-1 C-terminus; PCIF1 is expressed in beta cells and represses the insulin promoters.","method":"GST pulldown, co-immunoprecipitation, reporter assay, mutagenesis, immunofluorescence","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro binding plus in vivo co-IP plus functional reporter assay with mutagenesis in single study","pmids":["15121856"],"is_preprint":false},{"year":2005,"finding":"Bridge-1 (PDZ-domain coactivator) directly interacts with the amino-terminal transactivation domain of PDX-1 in GST pulldown assays and in yeast two-hybrid; Bridge-1 increases PDX-1 transactivation of somatostatin and insulin promoters, including synergistic activation of the rat insulin I promoter FarFlat enhancer together with E12 and E47.","method":"Yeast two-hybrid, GST pulldown, reporter assay with Gal4 fusion proteins","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction confirmed by GST pulldown and yeast two-hybrid, functional consequence shown by reporter assay; single lab","pmids":["15885879"],"is_preprint":false},{"year":2005,"finding":"Dominant-negative PDX-1 (DN-Pdx-1) in INS-1 cells causes defective glucose-stimulated and K+-depolarization-induced insulin secretion; DN-Pdx-1 downregulates FGFR1 and consequently prohormone convertases PC-1/3 and PC-2, severely impairing proinsulin processing; PDX-1 also regulates GLP-1 receptor expression, with DN-Pdx-1 reducing GLP-1R expression and cellular cAMP.","method":"Inducible dominant-negative cell lines, HPLC for insulin processing, patch-clamp capacitance, aequorin Ca2+ measurement, gene expression analysis","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal methods including electrophysiology, biochemical processing assay, and gene expression in inducible system","pmids":["15756539"],"is_preprint":false},{"year":2009,"finding":"KLF11 (MODY7) regulates PDX-1 transcription in beta cells through two conserved GC-rich motifs (GC1 and GC2) in the Area II enhancer; KLF11 specifically associates with Area II by ChIP; KLF11 interacts with the coactivator p300 via its zinc finger domain in vivo to mediate PDX-1 activation.","method":"Reporter assay, ChIP, co-immunoprecipitation, random oligonucleotide binding analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — chromatin occupancy by ChIP, direct protein interaction by co-IP, and functional reporter assay with mutagenesis in single study","pmids":["19843526"],"is_preprint":false},{"year":2009,"finding":"Pdx1 regulates a broad array of genes involved in ER function (disulfide bond formation, protein folding, unfolded protein response) as identified by high-throughput expression microarray and chromatin occupancy analyses; Pdx1 deficiency leads to ER stress and enhanced beta cell susceptibility to ER stress-associated apoptosis.","method":"Expression microarray, chromatin occupancy (ChIP) analysis, high-fat diet mouse model, Min6 cell knockdown","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — chromatin occupancy identifies direct targets, combined with loss-of-function phenotype and microarray; multiple orthogonal methods","pmids":["19855005"],"is_preprint":false},{"year":2010,"finding":"Protein kinase CK2 phosphorylates Pdx-1 at amino acids Thr231 and Ser232; this phosphorylation regulates Pdx-1 transcription factor activity as measured by insulin promoter reporter assay; inhibition of CK2 by specific inhibitors leads to elevated insulin release from beta cells.","method":"In vitro kinase assay with Pdx-1 fragments and phosphorylation mutants, reporter assay, CK2 inhibitor treatment","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct in vitro phosphorylation mapping with mutagenesis, single lab","pmids":["20339896"],"is_preprint":false},{"year":2011,"finding":"RB (retinoblastoma protein) associates with and stabilizes Pdx-1; Pdx-1 utilizes a conserved RB-interaction motif (RIM) also present in E2Fs; point mutations within the RIM reduce RB-Pdx-1 complex formation and promote Pdx-1 proteasomal degradation; glucose regulates RB/Pdx-1 complex formation and Pdx-1 stability; RB occupies promoters of beta-cell-specific genes.","method":"Co-immunoprecipitation, point mutagenesis, proteasome inhibitor assays, ChIP, RB knockdown, in vivo RB-deficient mice","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (co-IP, mutagenesis, ChIP, in vivo knockout), glucose-dependent regulation of complex","pmids":["21399612"],"is_preprint":false},{"year":2012,"finding":"Global Pdx1 chromatin occupancy analysis in mouse and human pancreatic islets by ChIP-seq identifies conserved target genes enriched for endocrine/metabolic functions; the conserved cistrome provides molecular explanation for Pdx1-deficiency phenotypes.","method":"ChIP-seq in mouse and human islets","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-scale direct chromatin occupancy in both human and mouse islets, replicated across species","pmids":["22322596"],"is_preprint":false},{"year":2013,"finding":"SIRT1 forms a protein complex with FOXA2 and other proteins on the Pdx1 gene promoter; SIRT1 deacetylates FOXA2 on the Pdx1 promoter and positively regulates Pdx1 transcription; pancreas-specific disruption of SIRT1 diminishes PDX1 expression and impairs islet development.","method":"Co-immunoprecipitation, ChIP, pancreas-specific Sirt1 knockout mice, deacetylation assay","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and ChIP establish complex formation and occupancy; in vivo knockout validates functional consequence; single lab","pmids":["24163589"],"is_preprint":false},{"year":2014,"finding":"Beta-cell-specific deletion of Pdx1 in adult mice causes rapid acquisition of alpha-cell ultrastructural and physiological features, including derepression of the alpha-cell transcription factor MafB; Pdx1 thus simultaneously activates beta-cell identity genes and represses alpha-cell identity genes, functioning as a master regulator of beta-cell fate.","method":"Conditional beta-cell-specific Pdx1 deletion, lineage tracing, transcriptomic profiling, electron microscopy, functional assays","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with fate mapping, transcriptomics, and multiple functional readouts; replicated across multiple analyses","pmids":["24506867"],"is_preprint":false},{"year":2015,"finding":"Pdx1 regulates mitophagy in beta cells by controlling expression of Clec16a (itself a regulator of mitophagy through E3 ubiquitin ligase Nrdp1); loss of Pdx1 reduces Clec16a and Nrdp1 expression and impairs autophagosome-lysosome fusion during mitophagy; restoration of Clec16a after Pdx1 loss rescues mitochondrial trafficking, respiration, and glucose-stimulated insulin release.","method":"Expression microarray, ChIP, conditional Pdx1 haploinsufficiency, Clec16a rescue experiments, mitophagy flux assays","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — chromatin occupancy identifies Clec16a as direct target; pathway placement confirmed by rescue experiment; multiple orthogonal methods","pmids":["26085571"],"is_preprint":false},{"year":2015,"finding":"Pdx1 directly binds and activates E-cadherin (E-cad/Cdh1) transcription through two conserved Pdx1 binding sites in the E-cad promoter; Pdx1 is required in vivo for maintenance of E-cad expression, actomyosin complex activity, and cell shape during pancreatic epithelial tubulogenesis and ductal plexus formation.","method":"ChIP, reporter assay, Pdx1-/- mouse embryo analysis, promoter mutagenesis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct binding by ChIP with promoter mutagenesis, functional consequence demonstrated in vivo","pmids":["26657766"],"is_preprint":false},{"year":2015,"finding":"HMGA1 physically interacts with PDX-1 and MafA both in vitro and in vivo; HMGA1 overexpression enhances PDX-1 and MafA transactivation of human and mouse insulin promoters; HMGA1 knockdown decreases this transactivating activity; high glucose increases HMGA1 binding to the insulin promoter.","method":"Co-immunoprecipitation, GST pulldown, reporter assay, ChIP, siRNA knockdown","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction by co-IP and GST pulldown, functional consequence by reporter assay and ChIP; single lab","pmids":["25628604"],"is_preprint":false},{"year":2018,"finding":"PDX1 forms a stress-inducible complex with ATF4 and ATF5; PDX1 occupies CARE (C/EBP-ATF) composite motifs at 26 genes involved in stress/apoptosis including Gpt2, Chac1, and Slc7a1; co-enrichment of ATF4 and ATF5 at these sites was confirmed by ChIP; deficiency of Gpt2 reduces beta-cell susceptibility to stress-induced apoptosis.","method":"Co-immunoprecipitation, ChIP-seq, RNAseq, gRNA/shRNA silencing, caspase-3 activation assay","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-scale ChIP-seq with co-IP and RNA-seq, functional validation by genetic silencing with defined apoptotic readout","pmids":["30174228"],"is_preprint":false},{"year":2018,"finding":"ChIP-seq of PDX1 in human iPSC-derived pancreatic progenitors identifies 8,088 binding regions mapping to 5,664 genes, including PDX1 auto-regulatory feedback on its own promoter, RFX6, HNF1B, MEIS1, RFX3, and DLL1; stage-specific comparison with adult islet PDX1 profiles reveals distinct developmental vs. adult target gene sets.","method":"ChIP-seq (PDX1 and H3K27ac) in iPSC-derived pancreatic progenitors vs. adult human islets, mRNA expression profiling","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-scale chromatin occupancy in two human developmental stages with active chromatin validation; comprehensive target identification","pmids":["29396371"],"is_preprint":false},{"year":2019,"finding":"Missense mutations in the PDX1 transactivation domain (P33T, C18R) impair PDX1-dependent gene expression and beta-cell differentiation; homozygous and heterozygous mutations reduce differentiation efficiency of pancreatic progenitors by downregulating PDX1-bound target genes including MNX1, PDX1 itself (autoregulation), CES1, MEG3, and NNAT.","method":"iPSC-derived isogenic cell lines with CRISPR-engineered mutations, in vitro beta-cell differentiation, gene expression profiling","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — isogenic iPSC system with defined mutations in transactivation domain, multiple orthogonal readouts of target gene expression","pmids":["30930126"],"is_preprint":false},{"year":2021,"finding":"Saturated fatty acids (palmitic acid) stimulate stress granule (SG) formation in beta cells via PI3K/EIF2α-dependent pathway; PDX1 and nucleocytoplasmic transport factors are sequestered in SGs, preventing nuclear localization of PDX1 and inhibiting glucose-induced insulin secretion; genetic deletion of TIA1 or pharmacological PI3K/EIF2α inhibition blocks SG formation, restores PDX1 nuclear localization, and ameliorates HFD-induced beta cell dysfunction.","method":"Immunofluorescence, mass spectrometry of SG components, nucleocytoplasmic transport reporters, TIA1 knockout mice, pharmacological inhibitors","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 / Strong — mass spectrometry identifies PDX1 in SGs, genetic and pharmacological rescue experiments validate mechanism, in vitro and in vivo validation","pmids":["33569632"],"is_preprint":false},{"year":2021,"finding":"OGT (O-GlcNAc transferase) deletion in beta cells reduces Pdx1 levels; Pdx1 overexpression rescues mitochondrial morphology and function, insulin content, and mitochondrial oxygen consumption in OGT-deficient islets, placing Pdx1 downstream of OGT in regulating mitochondrial biogenesis.","method":"Conditional OGT knockout, proteomics, Pdx1 overexpression rescue, mitochondrial respiration assay (Seahorse), electron microscopy","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rescue experiment establishes epistatic relationship; multiple orthogonal methods; single lab","pmids":["34462257"],"is_preprint":false},{"year":2024,"finding":"PDX1 silences NF-κB at circadian and inflammatory enhancers through long-range chromatin contacts involving SIN3A; single-cell chromatin analysis identifies beta cell subtypes with high vs. low PDX1 activity, with low-PDX1 cells showing increased chromatin accessibility at latent NF-κB enhancers; Pdx1 hypomorphic mice show de-repression of NF-κB and impaired nocturnal glucose tolerance; antagonizing the IL-1β receptor (an NF-κB target) improves insulin secretion in Pdx1 hypomorphic islets.","method":"Single-cell ATAC-seq, ChIP-seq, 3D chromatin analysis, Pdx1 hypomorphic mouse model, IL-1β receptor antagonism","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-scale chromatin methods with 3D contact analysis, genetic hypomorph model, and pharmacological rescue; multiple orthogonal approaches","pmids":["38171340"],"is_preprint":false},{"year":2005,"finding":"The P33T missense mutation in the PDX1/IPF1 transactivation domain reduces DNA-binding and transcriptional activation in vitro compared to wild-type IPF1, as measured by reporter gene assay.","method":"In vitro reporter gene assay with mutant IPF1 protein expression","journal":"Metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay of mutant protein; corroborated by later iPSC studies","pmids":["16092045"],"is_preprint":false},{"year":2001,"finding":"IPF1/PDX1 gene transfer to isolated Psammomys obesus islets (which lack functional IPF1/PDX1 protein) normalizes the defect in glucose-stimulated insulin gene expression and prevents rapid depletion of insulin content after high glucose exposure, directly linking PDX1 to glucose-responsive insulin gene transcription.","method":"IPF1/PDX1 gene transfer into isolated islets, Western blot, DNA binding assay, RT-PCR, immunostaining","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue by gene transfer in a naturally PDX1-deficient model; multiple assays confirming mechanism","pmids":["11473041"],"is_preprint":false},{"year":2003,"finding":"PDX-1 haploinsufficiency (Pdx1+/-) leads to increased beta-cell apoptosis associated with reduced Bcl-XL and Bcl-2 expression, abnormal islet architecture, active caspase-3, and failure of beta-cell mass expansion with age; glucose sensing and stimulus-secretion coupling in individual cells remain normal, indicating the organ-level insulin secretion defect is due to reduced beta-cell mass via increased apoptosis.","method":"Pdx1+/- mouse model, TUNEL, caspase-3 activation, electrophysiology, perifusion/static incubation, Western blot for Bcl-XL/Bcl-2","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple complementary methods including electrophysiology, apoptosis assays, and functional secretion studies; dissects organ- from cell-level defect","pmids":["12697734"],"is_preprint":false},{"year":2016,"finding":"PDX1 chromatin occupancy shifts profoundly between acinar cells and pancreatic ductal adenocarcinoma (PDA) cells, with PDX1 performing stage-specific functions: maintaining acinar cell identity (tumor-suppressive) vs. an oncogenic role in established PDA; PDX1 loss in malignant cells is associated with epithelial-to-mesenchymal transition.","method":"ChIP-seq in acinar cells and PDA, conditional PDX1 deletion/activation mouse models, lineage tracing","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-scale ChIP-seq across cell states with in vivo genetic models; multiple orthogonal methods","pmids":["28087712"],"is_preprint":false},{"year":2017,"finding":"Foxa2 and Pdx1 genetically and functionally cooperate to regulate postnatal beta-cell maturation; combined reduction of both Foxa2 and Pdx1 (in double knock-in reporter mice) causes hyperglycemia, loss of beta-cell identity, and transdifferentiation towards other endocrine cell fates, whereas reduction of either alone is insufficient.","method":"Double knock-in fluorescent reporter mouse (Foxa2-Venus; Pdx1-BFP), glucose tolerance testing, histological and transcriptional analysis","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in double knock-in model with functional phenotypic readout; single lab","pmids":["28580283"],"is_preprint":false},{"year":2005,"finding":"PDX-1 protein transduction occurs by endocytosis followed by release from endosomes; PDX-1 PTD is internalized via lipid raft-dependent macropinocytosis (blocked by amiloride and cytochalasin D but not by dominant-negative dynamin-1, ruling out clathrin- or caveolar-mediated endocytosis); internalized protein transits through the Golgi complex and ER before homogeneous cytoplasmic/nuclear distribution.","method":"Live-cell fluorescence imaging of FITC-PDX1-PTD, dominant-negative dynamin-1 expression, pharmacological inhibitors (amiloride, cytochalasin D), endosomal/Golgi markers","journal":"Biochemical and biophysical research communications / Cell transplantation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic dissection of uptake mechanism with live imaging; two concurrent papers from same group","pmids":["15896300","16405074"],"is_preprint":false}],"current_model":"PDX1 is a homeodomain transcription factor that directly binds TAAT-containing regulatory elements in target gene promoters (insulin, somatostatin, GLUT2, GIP, E-cadherin, and many others) through its homeodomain, recruits coactivators (Bridge-1, HMGA1, p300 via KLF11) and forms stress-induced complexes with ATF4/ATF5 at CARE motifs, while being repressed by PCIF1; its activity is regulated post-translationally by CK2-mediated phosphorylation at Thr231/Ser232, by RB-mediated stabilization against proteasomal degradation, by nuclear sequestration in saturated-fatty-acid-induced stress granules (via PI3K/EIF2α/TIA1), and by SIRT1-mediated deacetylation of its promoter regulator FOXA2; in beta cells PDX1 simultaneously activates beta-cell identity genes and represses alpha-cell programs (including via SIN3A-mediated long-range silencing of NF-κB enhancers), regulates ER protein-folding gene networks, and controls mitophagy through Clec16a-Nrdp1, making it a master regulator of pancreatic development, beta-cell identity, and beta-cell survival."},"narrative":{"mechanistic_narrative":"PDX1 is a homeodomain transcription factor that serves as a master regulator of pancreatic development and beta-cell identity, required for outgrowth, proliferation, and differentiation of the pancreatic progenitor pool [PMID:8631275]. Through its homeodomain it binds TAAT-containing regulatory elements to directly activate a conserved cistrome of endocrine and metabolic target genes, including somatostatin [PMID:7907546], GLUT2 [PMID:8923459], GIP [PMID:15486225], E-cadherin [PMID:26657766], and its own promoter via autoregulatory feedback [PMID:29396371], with cooperative DNA binding to Pbx (mediated by the FPWMK pentapeptide motif) restricting target selection [PMID:8524276]; its homeodomain mediates sequence-specific binding and nuclear localization while an N-terminal transactivation domain and C-terminal protein-interaction regions drive transactivation [PMID:8770920]. Genome-scale ChIP-seq across mouse and human islets, iPSC-derived progenitors, and tumor cells establishes that PDX1 occupancy is stage- and context-specific [PMID:22322596, PMID:29396371, PMID:28087712]. In mature beta cells PDX1 enforces beta-cell fate by simultaneously activating beta-cell identity genes and repressing the alpha-cell program, such that its deletion derepresses MafB and drives acquisition of alpha-cell features [PMID:24506867]; it also silences NF-κB at inflammatory enhancers through long-range chromatin contacts involving SIN3A [PMID:38171340]. Beyond identity, PDX1 controls beta-cell survival and metabolic competence by governing ER protein-folding gene networks [PMID:19855005], Clec16a-Nrdp1-dependent mitophagy [PMID:26085571], and glucose-stimulated insulin secretion and proinsulin processing [PMID:15756539, PMID:11473041]; haploinsufficiency increases beta-cell apoptosis and impairs mass expansion [PMID:12697734]. PDX1 activity is tuned post-translationally by CK2 phosphorylation at Thr231/Ser232 [PMID:20339896], RB-mediated stabilization against proteasomal degradation [PMID:21399612], and nuclear exclusion via sequestration into saturated-fatty-acid-induced stress granules [PMID:33569632], while its expression is set by upstream regulators including USF, HNF-3beta/BETA-2, KLF11, and SIRT1-deacetylated FOXA2 [PMID:8567692, PMID:9111329, PMID:19843526, PMID:24163589]. Missense mutations in its transactivation domain (P33T, C18R) impair target gene activation and beta-cell differentiation [PMID:30930126, PMID:16092045].","teleology":[{"year":1994,"claim":"Established that PDX1 is a sequence-specific DNA-binding transactivator by identifying its first direct genomic target, defining its molecular identity as a transcription factor.","evidence":"EMSA and promoter-reporter mutagenesis on the rat somatostatin gene","pmids":["7907546"],"confidence":"High","gaps":["Did not address genome-wide target repertoire","Promoter context only, no chromatin occupancy in vivo"]},{"year":1995,"claim":"Resolved how PDX1 achieves target selectivity by showing cooperative DNA binding with Pbx requires the FPWMK motif and homeodomain N-terminal arm, restricting occupancy to a subset of sites.","evidence":"EMSA with recombinant proteins and motif/domain mutagenesis","pmids":["8524276"],"confidence":"High","gaps":["In vitro reconstitution only","Which physiological targets depend on Pbx not enumerated"]},{"year":1996,"claim":"Demonstrated that PDX1 is genetically required for pancreatic development, establishing its master-regulator role beyond single-promoter regulation.","evidence":"Two independent null-allele knockout mice with histology and immunostaining","pmids":["8631275"],"confidence":"High","gaps":["Knockout does not separate progenitor proliferation from differentiation defects mechanistically","Direct target genes responsible for agenesis not defined"]},{"year":1996,"claim":"Mapped PDX1 functional domains, assigning DNA binding and nuclear localization to the homeodomain and transactivation to the N-terminus, providing a structure-function framework.","evidence":"Deletion/point mutagenesis with EMSA, reporter assay, and nuclear fractionation","pmids":["8770920"],"confidence":"High","gaps":["No structural model of the domains","Identity of C-terminal interaction partners not yet known"]},{"year":1996,"claim":"Extended the direct target set to GLUT2, linking PDX1 to beta-cell glucose-sensing gene expression.","evidence":"EMSA with antibody supershift, reporter mutagenesis of the GLUT2TAAT motif","pmids":["8923459"],"confidence":"High","gaps":["Residual promoter activity after motif mutation indicates other inputs","In vivo occupancy not shown in this study"]},{"year":1996,"claim":"Defined the upstream regulatory architecture of the PDX1 gene itself, identifying a distal enhancer and proximal USF-bound E-box required for islet-specific expression.","evidence":"Transgenic reporter assays, mutagenesis, EMSA","pmids":["8567692"],"confidence":"High","gaps":["Full enhancer composition not exhaustively mapped","Does not address dynamic regulation"]},{"year":1997,"claim":"Connected PDX1 expression to hormonal and metabolic signals, showing HNF-3beta/BETA-2 control of its enhancer and glucocorticoid repression.","evidence":"Reporter assays with overexpression and GR-mediated inhibition","pmids":["9111329"],"confidence":"Medium","gaps":["Single-lab reporter-based mechanism","No in vivo glucocorticoid validation"]},{"year":1997,"claim":"Identified lipotoxic suppression of PDX1, showing palmitate lowers PDX1 expression and DNA-binding via mitochondrial fatty-acid oxidation, linking PDX1 to beta-cell metabolic stress.","evidence":"Western blot, EMSA, RT-PCR with CPT-I inhibitor in primary rat islets","pmids":["9374511"],"confidence":"High","gaps":["Did not identify the molecular signal connecting oxidation to PDX1 loss","Distinguishing transcriptional vs post-transcriptional control incomplete"]},{"year":1998,"claim":"Showed PDX1 is dynamically and reversibly downregulated by elevated glucose through a post-transcriptional mechanism, indicating rapid environmental tuning of its abundance.","evidence":"Reporter assay, EMSA, Northern/RT-PCR in INS-1 cells","pmids":["9482663"],"confidence":"Medium","gaps":["Post-transcriptional mechanism not molecularly defined","Single cell-line context"]},{"year":1998,"claim":"Revealed PDX1 can act as a transcriptional antagonist of another homeodomain factor (Cdx-2), explaining gut dysmorphogenesis on ectopic expression.","evidence":"Transgenic mouse, reporter assay, protein-interaction analysis","pmids":["9679043"],"confidence":"Medium","gaps":["Mechanism of inhibition (binding vs squelching) not fully resolved","Ectopic-expression context limits physiological relevance"]},{"year":2001,"claim":"Provided causal rescue evidence that PDX1 drives glucose-responsive insulin gene transcription, by restoring function in a naturally PDX1-deficient islet model.","evidence":"IPF1/PDX1 gene transfer into Psammomys obesus islets with DNA binding and expression assays","pmids":["11473041"],"confidence":"Medium","gaps":["Overexpression rescue may not mirror endogenous stoichiometry","Single model system"]},{"year":2003,"claim":"Distinguished organ-level from cell-level secretion defects, showing PDX1 haploinsufficiency reduces beta-cell mass through increased apoptosis rather than impairing single-cell glucose sensing.","evidence":"Pdx1+/- mice with TUNEL, caspase-3, electrophysiology, perifusion, Bcl-XL/Bcl-2 Western","pmids":["12697734"],"confidence":"High","gaps":["Direct PDX1 targets controlling survival genes not defined here","Mechanism linking PDX1 dose to apoptosis incomplete"]},{"year":2004,"claim":"Identified PCIF1 as a direct C-terminal-binding repressor of PDX1, defining a negative regulator of its transactivation in beta cells.","evidence":"GST pulldown, co-IP, reporter assay, mutagenesis, immunofluorescence","pmids":["15121856"],"confidence":"High","gaps":["In vivo physiological role of PCIF1 repression not established","Single study"]},{"year":2004,"claim":"Confirmed direct in-cell chromatin occupancy of PDX1 at the GIP promoter, extending PDX1 control to enteroendocrine cell-specific gene expression.","evidence":"ChIP, EMSA, reporter assay, and GIP cell quantification in PDX-1 null mice","pmids":["15486225"],"confidence":"High","gaps":["Cofactors at the GIP promoter not identified","Tissue-specificity determinants unaddressed"]},{"year":2005,"claim":"Identified Bridge-1 as a coactivator binding the PDX1 transactivation domain, beginning to define the coactivator network amplifying PDX1 output.","evidence":"Yeast two-hybrid, GST pulldown, reporter assays with Gal4 fusions","pmids":["15885879"],"confidence":"Medium","gaps":["No in vivo validation","Single-lab interaction data"]},{"year":2005,"claim":"Defined the consequences of disrupting PDX1 function on insulin biology, showing it controls proinsulin processing (via FGFR1/PC1/3/PC2) and incretin signaling (GLP-1R), broadening its role beyond transcription of insulin itself.","evidence":"Inducible dominant-negative INS-1 cells with HPLC processing, patch-clamp, Ca2+ measurement, expression analysis","pmids":["15756539"],"confidence":"High","gaps":["Dominant-negative may affect non-physiological targets","Direct vs indirect regulation of each gene not fully parsed"]},{"year":2005,"claim":"First functional characterization of a disease-associated PDX1 mutation, showing P33T impairs DNA binding and transactivation.","evidence":"In vitro reporter assay with mutant IPF1 protein","pmids":["16092045"],"confidence":"Medium","gaps":["In vitro only; cellular and developmental consequences addressed later","Single mutation"]},{"year":2005,"claim":"Characterized the cellular uptake route of exogenous PDX1 protein transduction domain, relevant to its use as a delivered reprogramming factor.","evidence":"Live-cell imaging, dominant-negative dynamin, pharmacological inhibitors, organelle markers","pmids":["15896300","16405074"],"confidence":"Medium","gaps":["Describes engineered transduction, not endogenous PDX1 trafficking","Two papers from same group"]},{"year":2009,"claim":"Established the regulatory circuit setting PDX1 levels, showing KLF11 activates the PDX1 Area II enhancer through GC motifs and recruits p300.","evidence":"Reporter assay, ChIP, co-IP, oligonucleotide binding analysis","pmids":["19843526"],"confidence":"High","gaps":["In vivo requirement of KLF11 for PDX1 expression not shown here","Single study"]},{"year":2009,"claim":"Linked PDX1 to beta-cell survival mechanistically by showing it directly regulates ER protein-folding gene networks, with deficiency causing ER stress and apoptosis susceptibility.","evidence":"Expression microarray, ChIP occupancy, high-fat diet model, Min6 knockdown","pmids":["19855005"],"confidence":"High","gaps":["Individual critical ER targets not pinpointed","Direct vs secondary effects within the network unresolved"]},{"year":2010,"claim":"Identified CK2 phosphorylation of PDX1 at Thr231/Ser232 as a post-translational modulator of its transcriptional activity and insulin release.","evidence":"In vitro kinase assay with phosphomutants, reporter assay, CK2 inhibitor treatment","pmids":["20339896"],"confidence":"Medium","gaps":["In vivo phosphorylation state not quantified","Single lab"]},{"year":2011,"claim":"Defined glucose-regulated PDX1 protein stability, showing RB binds a conserved RIM motif to protect PDX1 from proteasomal degradation.","evidence":"Co-IP, point mutagenesis, proteasome inhibition, ChIP, RB knockdown, RB-deficient mice","pmids":["21399612"],"confidence":"High","gaps":["E3 ligase targeting PDX1 not identified","How glucose signals to the complex unresolved"]},{"year":2012,"claim":"Defined the conserved PDX1 cistrome across mouse and human islets, providing genome-scale molecular explanation for deficiency phenotypes.","evidence":"ChIP-seq in mouse and human islets","pmids":["22322596"],"confidence":"High","gaps":["Occupancy does not establish functional dependence for each gene","Cell-type heterogeneity within islets not resolved"]},{"year":2013,"claim":"Placed SIRT1 upstream of PDX1, showing SIRT1 deacetylates FOXA2 on the PDX1 promoter to positively control its transcription and islet development.","evidence":"Co-IP, ChIP, pancreas-specific Sirt1 knockout, deacetylation assay","pmids":["24163589"],"confidence":"Medium","gaps":["Direct vs indirect SIRT1 effects on FOXA2 acetylation in vivo","Single lab"]},{"year":2014,"claim":"Established PDX1 as an active enforcer of beta-cell identity that represses the alpha-cell program, since its loss in adult beta cells triggers acquisition of alpha-cell features and MafB derepression.","evidence":"Conditional beta-cell Pdx1 deletion with lineage tracing, transcriptomics, EM, functional assays","pmids":["24506867"],"confidence":"High","gaps":["Mechanism of alpha-gene repression not yet molecular in this study","Reversibility of identity loss unaddressed"]},{"year":2015,"claim":"Defined a developmental morphogenesis function, showing PDX1 directly activates E-cadherin to maintain epithelial cell shape during pancreatic tubulogenesis.","evidence":"ChIP, reporter assay, promoter mutagenesis, Pdx1-/- embryo analysis","pmids":["26657766"],"confidence":"High","gaps":["Link between E-cadherin loss and overall ductal phenotype partly correlative","Other adhesion targets not surveyed"]},{"year":2015,"claim":"Connected PDX1 to organelle quality control, showing it directly controls Clec16a-Nrdp1-dependent mitophagy required for beta-cell respiration and insulin secretion.","evidence":"Microarray, ChIP, conditional haploinsufficiency, Clec16a rescue, mitophagy flux assays","pmids":["26085571"],"confidence":"High","gaps":["Whether mitophagy defect alone accounts for secretion loss not isolated","Other autophagy targets not examined"]},{"year":2015,"claim":"Added HMGA1 as a glucose-responsive coactivator enhancing PDX1/MafA transactivation of the insulin promoter.","evidence":"Co-IP, GST pulldown, reporter assay, ChIP, siRNA","pmids":["25628604"],"confidence":"Medium","gaps":["No in vivo validation","Single lab"]},{"year":2016,"claim":"Revealed context-dependent, even opposing, PDX1 functions, showing its cistrome and role shift from acinar identity maintenance (tumor-suppressive) to oncogenic in pancreatic ductal adenocarcinoma.","evidence":"ChIP-seq in acinar and PDA cells, conditional deletion/activation mouse models, lineage tracing","pmids":["28087712"],"confidence":"High","gaps":["Determinants of the cistrome switch not defined","Cofactors driving oncogenic redirection unknown"]},{"year":2017,"claim":"Demonstrated genetic cooperation between PDX1 and FOXA2 in postnatal beta-cell maturation, showing combined dose reduction—but not either alone—causes identity loss and transdifferentiation.","evidence":"Double knock-in reporter mice, glucose tolerance testing, histology and transcriptional analysis","pmids":["28580283"],"confidence":"Medium","gaps":["Shared vs distinct target genes not fully resolved","Single lab"]},{"year":2018,"claim":"Identified a stress-inducible mode of PDX1 action, showing it forms complexes with ATF4/ATF5 at CARE motifs to regulate stress/apoptosis genes such that Gpt2 loss reduces apoptotic susceptibility.","evidence":"Co-IP, ChIP-seq, RNA-seq, genetic silencing, caspase-3 assay","pmids":["30174228"],"confidence":"High","gaps":["Trigger conditions for complex assembly not fully defined","Direction of PDX1 effect (pro- vs anti-apoptotic) context-dependent"]},{"year":2018,"claim":"Defined the developmental PDX1 cistrome in human iPSC-derived progenitors, revealing autoregulation and stage-specific targets distinct from adult islets.","evidence":"ChIP-seq (PDX1, H3K27ac) in iPSC progenitors vs adult islets with expression profiling","pmids":["29396371"],"confidence":"High","gaps":["Functional dependence of each developmental target not tested","iPSC progenitors may not fully recapitulate in vivo development"]},{"year":2019,"claim":"Provided causal disease-relevant evidence that transactivation-domain mutations (P33T, C18R) impair PDX1 target activation and beta-cell differentiation in an isogenic human system.","evidence":"CRISPR-engineered isogenic iPSC lines, in vitro beta-cell differentiation, expression profiling","pmids":["30930126"],"confidence":"High","gaps":["Mechanism of transactivation-domain loss at molecular level not detailed","Patient-level phenotype correlation outside scope"]},{"year":2021,"claim":"Identified a non-transcriptional regulatory layer, showing saturated fatty acids sequester PDX1 in stress granules via PI3K/EIF2α/TIA1, blocking its nuclear localization and insulin secretion.","evidence":"Immunofluorescence, mass spectrometry of SG components, transport reporters, TIA1 knockout mice, inhibitors","pmids":["33569632"],"confidence":"High","gaps":["How PDX1 is selectively recruited to stress granules unknown","Reversibility kinetics in vivo not fully quantified"]},{"year":2021,"claim":"Placed PDX1 downstream of OGT in mitochondrial regulation, showing PDX1 re-expression rescues mitochondrial function in OGT-deficient beta cells.","evidence":"Conditional OGT knockout, proteomics, Pdx1 overexpression rescue, Seahorse respiration, EM","pmids":["34462257"],"confidence":"Medium","gaps":["Whether OGT acts on PDX1 directly or via its expression unresolved","Single lab"]},{"year":2024,"claim":"Defined a long-range repressive mechanism, showing PDX1 silences NF-κB at inflammatory/circadian enhancers via SIN3A-mediated chromatin contacts, with low-PDX1 beta cells showing NF-κB derepression rescuable by IL-1β receptor antagonism.","evidence":"Single-cell ATAC-seq, ChIP-seq, 3D chromatin analysis, Pdx1 hypomorphic mice, IL-1βR antagonism","pmids":["38171340"],"confidence":"High","gaps":["How PDX1 directs SIN3A to specific enhancers not detailed","Causal link between subtype heterogeneity and disease not fully established"]},{"year":null,"claim":"It remains unresolved how the diverse upstream inputs (CK2, RB, OGT, stress granules) are integrated to set PDX1 dose and activity in vivo, and what determines the context-specific cistrome switches between development, mature beta cells, and tumor states.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating transcriptional, post-translational, and localization control","Determinants of context-dependent target selection unknown","Cofactor requirements for repressive vs activating modes not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,6,10,18,20,22,24,25,29]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,2,3,6,30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,27]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[18,25,29]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,2,10,18,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,20,22,26]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[15,24,27]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[24,32]}],"complexes":[],"partners":["PBX1","PCIF1","RB1","KLF11","HMGA1","ATF4","ATF5","SIN3A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P52945","full_name":"Pancreas/duodenum homeobox protein 1","aliases":["Glucose-sensitive factor","GSF","Insulin promoter factor 1","IPF-1","Insulin upstream factor 1","IUF-1","Islet/duodenum homeobox-1","IDX-1","Somatostatin-transactivating factor 1","STF-1"],"length_aa":283,"mass_kda":30.8,"function":"Activates insulin, somatostatin, glucokinase, islet amyloid polypeptide and glucose transporter type 2 gene transcription. Particularly involved in glucose-dependent regulation of insulin gene transcription. As part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Binds preferentially the DNA motif 5'-[CT]TAAT[TG]-3'. During development, specifies the early pancreatic epithelium, permitting its proliferation, branching and subsequent differentiation. At adult stage, required for maintaining the hormone-producing phenotype of the beta-cell","subcellular_location":"Nucleus; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/P52945/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDX1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDX1","total_profiled":1310},"omim":[{"mim_id":"621241","title":"PDX1-ASSOCIATED LONG NONCODING RNA, UPREGULATOR OF TRANSCRIPTION; PLUT","url":"https://www.omim.org/entry/621241"},{"mim_id":"619321","title":"GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF","url":"https://www.omim.org/entry/619321"},{"mim_id":"618500","title":"HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12","url":"https://www.omim.org/entry/618500"},{"mim_id":"616511","title":"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14","url":"https://www.omim.org/entry/616511"},{"mim_id":"610303","title":"MAF bZIP TRANSCRIPTION FACTOR A; MAFA","url":"https://www.omim.org/entry/610303"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":39.4},{"tissue":"pancreas","ntpm":12.2}],"url":"https://www.proteinatlas.org/search/PDX1"},"hgnc":{"alias_symbol":["IDX-1","STF-1","PDX-1","MODY4","GSF","IUF-1"],"prev_symbol":["IPF1"]},"alphafold":{"accession":"P52945","domains":[{"cath_id":"1.10.10.60","chopping":"155-205","consensus_level":"medium","plddt":98.0308,"start":155,"end":205}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P52945","model_url":"https://alphafold.ebi.ac.uk/files/AF-P52945-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P52945-F1-predicted_aligned_error_v6.png","plddt_mean":64.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDX1","jax_strain_url":"https://www.jax.org/strain/search?query=PDX1"},"sequence":{"accession":"P52945","fasta_url":"https://rest.uniprot.org/uniprotkb/P52945.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P52945/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P52945"}},"corpus_meta":[{"pmid":"8631275","id":"PMC_8631275","title":"PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8631275","citation_count":1294,"is_preprint":false},{"pmid":"7867492","id":"PMC_7867492","title":"Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7867492","citation_count":494,"is_preprint":false},{"pmid":"10905482","id":"PMC_10905482","title":"Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10905482","citation_count":464,"is_preprint":false},{"pmid":"7907546","id":"PMC_7907546","title":"IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7907546","citation_count":397,"is_preprint":false},{"pmid":"24506867","id":"PMC_24506867","title":"Pdx1 maintains β cell identity and function by repressing an α cell program.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24506867","citation_count":356,"is_preprint":false},{"pmid":"8923459","id":"PMC_8923459","title":"Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor.","date":"1996","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8923459","citation_count":308,"is_preprint":false},{"pmid":"12697734","id":"PMC_12697734","title":"Increased islet apoptosis in Pdx1+/- mice.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12697734","citation_count":294,"is_preprint":false},{"pmid":"10078550","id":"PMC_10078550","title":"The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration.","date":"1999","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10078550","citation_count":280,"is_preprint":false},{"pmid":"22570331","id":"PMC_22570331","title":"Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.","date":"2012","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22570331","citation_count":236,"is_preprint":false},{"pmid":"29096722","id":"PMC_29096722","title":"PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.","date":"2017","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29096722","citation_count":233,"is_preprint":false},{"pmid":"9374511","id":"PMC_9374511","title":"Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9374511","citation_count":211,"is_preprint":false},{"pmid":"11692168","id":"PMC_11692168","title":"Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function.","date":"2001","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/11692168","citation_count":197,"is_preprint":false},{"pmid":"19855005","id":"PMC_19855005","title":"Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19855005","citation_count":188,"is_preprint":false},{"pmid":"19817786","id":"PMC_19817786","title":"Pdx1 and other factors that regulate pancreatic beta-cell survival.","date":"2009","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19817786","citation_count":178,"is_preprint":false},{"pmid":"11994408","id":"PMC_11994408","title":"Pdx1 restores beta cell function in Irs2 knockout mice.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11994408","citation_count":154,"is_preprint":false},{"pmid":"18294628","id":"PMC_18294628","title":"Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cells.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18294628","citation_count":151,"is_preprint":false},{"pmid":"8524276","id":"PMC_8524276","title":"The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8524276","citation_count":141,"is_preprint":false},{"pmid":"17938503","id":"PMC_17938503","title":"PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function.","date":"2007","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/17938503","citation_count":127,"is_preprint":false},{"pmid":"9492081","id":"PMC_9492081","title":"Conservation of PDX-1 structure, function, and expression in zebrafish.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9492081","citation_count":118,"is_preprint":false},{"pmid":"9000703","id":"PMC_9000703","title":"Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9000703","citation_count":115,"is_preprint":false},{"pmid":"17226789","id":"PMC_17226789","title":"Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17226789","citation_count":102,"is_preprint":false},{"pmid":"12145164","id":"PMC_12145164","title":"PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12145164","citation_count":102,"is_preprint":false},{"pmid":"10537169","id":"PMC_10537169","title":"Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter.","date":"1999","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10537169","citation_count":99,"is_preprint":false},{"pmid":"14550306","id":"PMC_14550306","title":"Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14550306","citation_count":98,"is_preprint":false},{"pmid":"9111329","id":"PMC_9111329","title":"Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9111329","citation_count":97,"is_preprint":false},{"pmid":"36589234","id":"PMC_36589234","title":"PDX1 is the cornerstone of pancreatic β-cell functions and identity.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36589234","citation_count":91,"is_preprint":false},{"pmid":"15028942","id":"PMC_15028942","title":"PDX-1 and the pancreas.","date":"2004","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/15028942","citation_count":90,"is_preprint":false},{"pmid":"19843526","id":"PMC_19843526","title":"MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19843526","citation_count":86,"is_preprint":false},{"pmid":"15153417","id":"PMC_15153417","title":"Transcription factors in islet development and physiology: role of PDX-1 in beta-cell function.","date":"2004","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15153417","citation_count":85,"is_preprint":false},{"pmid":"28087712","id":"PMC_28087712","title":"PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/28087712","citation_count":82,"is_preprint":false},{"pmid":"8567692","id":"PMC_8567692","title":"Pancreatic islet expression of the homeobox factor STF-1 relies on an E-box motif that binds USF.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8567692","citation_count":81,"is_preprint":false},{"pmid":"15862113","id":"PMC_15862113","title":"Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15862113","citation_count":81,"is_preprint":false},{"pmid":"29396371","id":"PMC_29396371","title":"Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.","date":"2018","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29396371","citation_count":76,"is_preprint":false},{"pmid":"22498824","id":"PMC_22498824","title":"PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22498824","citation_count":72,"is_preprint":false},{"pmid":"26085571","id":"PMC_26085571","title":"Diabetes Susceptibility Genes Pdx1 and Clec16a Function in a Pathway Regulating Mitophagy in β-Cells.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26085571","citation_count":71,"is_preprint":false},{"pmid":"19755420","id":"PMC_19755420","title":"Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19755420","citation_count":71,"is_preprint":false},{"pmid":"12947327","id":"PMC_12947327","title":"Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer.","date":"2003","source":"Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/12947327","citation_count":70,"is_preprint":false},{"pmid":"28580283","id":"PMC_28580283","title":"Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells.","date":"2017","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28580283","citation_count":69,"is_preprint":false},{"pmid":"10588826","id":"PMC_10588826","title":"PDX-1 and Msx-2 expression in the regenerating and developing pancreas.","date":"1999","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10588826","citation_count":69,"is_preprint":false},{"pmid":"30930126","id":"PMC_30930126","title":"Point mutations in the PDX1 transactivation domain impair human β-cell development and function.","date":"2019","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30930126","citation_count":68,"is_preprint":false},{"pmid":"15652518","id":"PMC_15652518","title":"Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15652518","citation_count":67,"is_preprint":false},{"pmid":"15756539","id":"PMC_15756539","title":"Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.","date":"2005","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/15756539","citation_count":62,"is_preprint":false},{"pmid":"33514698","id":"PMC_33514698","title":"PDX1LOW MAFALOW β-cells contribute to islet function and insulin release.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33514698","citation_count":61,"is_preprint":false},{"pmid":"11473041","id":"PMC_11473041","title":"IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal With type 2 diabetes.","date":"2001","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11473041","citation_count":60,"is_preprint":false},{"pmid":"17383157","id":"PMC_17383157","title":"Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.","date":"2007","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/17383157","citation_count":57,"is_preprint":false},{"pmid":"15896300","id":"PMC_15896300","title":"Mechanism of PDX-1 protein transduction.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15896300","citation_count":57,"is_preprint":false},{"pmid":"9482663","id":"PMC_9482663","title":"Glucose rapidly and reversibly decreases INS-1 cell insulin gene transcription via decrements in STF-1 and C1 activator transcription factor activity.","date":"1998","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9482663","citation_count":56,"is_preprint":false},{"pmid":"16092045","id":"PMC_16092045","title":"IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.","date":"2005","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/16092045","citation_count":55,"is_preprint":false},{"pmid":"22322596","id":"PMC_22322596","title":"Research resource: the pdx1 cistrome of pancreatic islets.","date":"2012","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22322596","citation_count":54,"is_preprint":false},{"pmid":"15121856","id":"PMC_15121856","title":"Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15121856","citation_count":53,"is_preprint":false},{"pmid":"8770920","id":"PMC_8770920","title":"Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene.","date":"1996","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8770920","citation_count":52,"is_preprint":false},{"pmid":"11270685","id":"PMC_11270685","title":"Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.","date":"2001","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/11270685","citation_count":50,"is_preprint":false},{"pmid":"21297446","id":"PMC_21297446","title":"Pdx1 expression in pancreatic precursor lesions and neoplasms.","date":"2011","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/21297446","citation_count":48,"is_preprint":false},{"pmid":"35063660","id":"PMC_35063660","title":"PDX1.1-dependent biosynthesis of vitamin B6 protects roots from ammonium-induced oxidative stress.","date":"2022","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/35063660","citation_count":47,"is_preprint":false},{"pmid":"17627512","id":"PMC_17627512","title":"Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells.","date":"2007","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17627512","citation_count":45,"is_preprint":false},{"pmid":"36551213","id":"PMC_36551213","title":"PDX-1: A Promising Therapeutic Target to Reverse Diabetes.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36551213","citation_count":44,"is_preprint":false},{"pmid":"18508668","id":"PMC_18508668","title":"PDX-1 functions as a master factor in the pancreas.","date":"2008","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/18508668","citation_count":44,"is_preprint":false},{"pmid":"25628604","id":"PMC_25628604","title":"Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells.","date":"2015","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25628604","citation_count":43,"is_preprint":false},{"pmid":"16938521","id":"PMC_16938521","title":"Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma.","date":"2006","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16938521","citation_count":42,"is_preprint":false},{"pmid":"9679043","id":"PMC_9679043","title":"Misexpression of the pancreatic homeodomain protein IDX-1 by the Hoxa-4 promoter associated with agenesis of the cecum.","date":"1998","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/9679043","citation_count":42,"is_preprint":false},{"pmid":"24163589","id":"PMC_24163589","title":"SIRT1 deacetylates FOXA2 and is critical for Pdx1 transcription and β-cell formation.","date":"2013","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24163589","citation_count":42,"is_preprint":false},{"pmid":"15486225","id":"PMC_15486225","title":"Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1.","date":"2004","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15486225","citation_count":42,"is_preprint":false},{"pmid":"21108535","id":"PMC_21108535","title":"NKX6.1 promotes PDX-1-induced liver to pancreatic β-cells reprogramming.","date":"2010","source":"Cellular reprogramming","url":"https://pubmed.ncbi.nlm.nih.gov/21108535","citation_count":41,"is_preprint":false},{"pmid":"6185535","id":"PMC_6185535","title":"Glia cell stimulating factor (GSF): a new lymphokine. Part 1. Cellular sources and partial purification of murine GSF, role of cytoskeleton and protein synthesis in its production.","date":"1982","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/6185535","citation_count":41,"is_preprint":false},{"pmid":"19689288","id":"PMC_19689288","title":"Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells.","date":"2009","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19689288","citation_count":39,"is_preprint":false},{"pmid":"16405074","id":"PMC_16405074","title":"PDX-1 protein is internalized by lipid raft-dependent macropinocytosis.","date":"2005","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/16405074","citation_count":39,"is_preprint":false},{"pmid":"17449132","id":"PMC_17449132","title":"Role of PDX-1 and MafA as a potential therapeutic target for diabetes.","date":"2007","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/17449132","citation_count":38,"is_preprint":false},{"pmid":"20339896","id":"PMC_20339896","title":"CK2 phosphorylation of Pdx-1 regulates its transcription factor activity.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20339896","citation_count":38,"is_preprint":false},{"pmid":"27615141","id":"PMC_27615141","title":"Impact of Pdx1-associated chromatin modifiers on islet β-cells.","date":"2016","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27615141","citation_count":35,"is_preprint":false},{"pmid":"33564250","id":"PMC_33564250","title":"Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus.","date":"2021","source":"Diabetes, metabolic syndrome and obesity : targets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33564250","citation_count":34,"is_preprint":false},{"pmid":"6185536","id":"PMC_6185536","title":"Glia cell stimulating factor (GSF): a new lymphokine. Part 2. Cellular sources and partial purification of human GSF.","date":"1982","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/6185536","citation_count":33,"is_preprint":false},{"pmid":"22028850","id":"PMC_22028850","title":"Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22028850","citation_count":33,"is_preprint":false},{"pmid":"36187092","id":"PMC_36187092","title":"Regulation of Pdx1 by oxidative stress and Nrf2 in pancreatic beta-cells.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36187092","citation_count":32,"is_preprint":false},{"pmid":"24290880","id":"PMC_24290880","title":"A small-molecule inducer of PDX1 expression identified by high-throughput screening.","date":"2013","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/24290880","citation_count":32,"is_preprint":false},{"pmid":"16461554","id":"PMC_16461554","title":"Involvement of PDX-1 in activation of human insulin gene transcription.","date":"2006","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16461554","citation_count":31,"is_preprint":false},{"pmid":"12389618","id":"PMC_12389618","title":"Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation.","date":"2002","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/12389618","citation_count":30,"is_preprint":false},{"pmid":"15300214","id":"PMC_15300214","title":"Hepatic regeneration and enforced PDX-1 expression accelerate transdifferentiation in liver.","date":"2004","source":"Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/15300214","citation_count":30,"is_preprint":false},{"pmid":"31337977","id":"PMC_31337977","title":"Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.","date":"2019","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31337977","citation_count":30,"is_preprint":false},{"pmid":"18477649","id":"PMC_18477649","title":"Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer.","date":"2008","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18477649","citation_count":30,"is_preprint":false},{"pmid":"9312185","id":"PMC_9312185","title":"Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9312185","citation_count":28,"is_preprint":false},{"pmid":"26657766","id":"PMC_26657766","title":"Pdx1 regulates pancreas tubulogenesis and E-cadherin expression.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26657766","citation_count":28,"is_preprint":false},{"pmid":"17583748","id":"PMC_17583748","title":"PDX-1 expression is associated with islet proliferation in vitro and in vivo.","date":"2007","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/17583748","citation_count":28,"is_preprint":false},{"pmid":"21385937","id":"PMC_21385937","title":"Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone-induced pancreatic β-cells dysfunction.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21385937","citation_count":28,"is_preprint":false},{"pmid":"30353648","id":"PMC_30353648","title":"Liraglutide protects against glucolipotoxicity-induced RIN-m5F β-cell apoptosis through restoration of PDX1 expression.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30353648","citation_count":28,"is_preprint":false},{"pmid":"31887289","id":"PMC_31887289","title":"Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31887289","citation_count":28,"is_preprint":false},{"pmid":"30174228","id":"PMC_30174228","title":"A PDX1-ATF transcriptional complex governs β cell survival during stress.","date":"2018","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30174228","citation_count":27,"is_preprint":false},{"pmid":"32166879","id":"PMC_32166879","title":"Generation of viable PDX1 gene-edited founder pigs as providers of nonmosaics.","date":"2020","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/32166879","citation_count":27,"is_preprint":false},{"pmid":"28017717","id":"PMC_28017717","title":"Preserving expression of Pdx1 improves β-cell failure in diabetic mice.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28017717","citation_count":26,"is_preprint":false},{"pmid":"33569632","id":"PMC_33569632","title":"Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function.","date":"2021","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/33569632","citation_count":26,"is_preprint":false},{"pmid":"20467340","id":"PMC_20467340","title":"Reduced expression of PDX-1 is associated with decreased beta cell function in chronic pancreatitis.","date":"2010","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/20467340","citation_count":26,"is_preprint":false},{"pmid":"38171340","id":"PMC_38171340","title":"Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneity.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38171340","citation_count":25,"is_preprint":false},{"pmid":"24176839","id":"PMC_24176839","title":"Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.","date":"2013","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24176839","citation_count":25,"is_preprint":false},{"pmid":"20589757","id":"PMC_20589757","title":"SREBP-1c, Pdx-1, and GLP-1R involved in palmitate-EPA regulated glucose-stimulated insulin secretion in INS-1 cells.","date":"2010","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20589757","citation_count":25,"is_preprint":false},{"pmid":"21399612","id":"PMC_21399612","title":"RB regulates pancreas development by stabilizing Pdx1.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21399612","citation_count":25,"is_preprint":false},{"pmid":"34462257","id":"PMC_34462257","title":"OGT Regulates Mitochondrial Biogenesis and Function via Diabetes Susceptibility Gene Pdx1.","date":"2021","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/34462257","citation_count":24,"is_preprint":false},{"pmid":"15885879","id":"PMC_15885879","title":"The coactivator Bridge-1 increases transcriptional activation by pancreas duodenum homeobox-1 (PDX-1).","date":"2005","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15885879","citation_count":24,"is_preprint":false},{"pmid":"18036209","id":"PMC_18036209","title":"Gene array identification of Ipf1/Pdx1-/- regulated genes in pancreatic progenitor cells.","date":"2007","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18036209","citation_count":24,"is_preprint":false},{"pmid":"25845046","id":"PMC_25845046","title":"PDX-1 (pancreatic/duodenal homeobox-1 protein 1).","date":"2014","source":"Pathologica","url":"https://pubmed.ncbi.nlm.nih.gov/25845046","citation_count":23,"is_preprint":false},{"pmid":"34988346","id":"PMC_34988346","title":"First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications.","date":"2021","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/34988346","citation_count":23,"is_preprint":false},{"pmid":"15037986","id":"PMC_15037986","title":"The role of pdx1 and HNF6 in proliferation and differentiation of endocrine precursors.","date":"2004","source":"Diabetes/metabolism research and reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15037986","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50726,"output_tokens":8838,"usd":0.142374,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18929,"output_tokens":8722,"usd":0.156348,"stage2_stop_reason":"end_turn"},"total_usd":0.298722,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"PDX-1 (pdx-1) null mutation in mice results in failure of pancreatic bud outgrowth beyond initial formation; the dorsal bud forms but undergoes only limited proliferation without insulin or amylase-positive cells, demonstrating PDX-1 is required for pancreatic progenitor proliferation and differentiation. Additionally, the rostral duodenum shows loss of normal columnar epithelium replaced by GLUT2-positive cuboidal epithelium.\",\n      \"method\": \"Gene targeting / knockout mouse (two independent null alleles including lacZ knock-in), histology, immunostaining\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — two independent null alleles with rigorous histological analysis, replicated finding of pancreatic agenesis\",\n      \"pmids\": [\"8631275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"IDX-1 (PDX1) binds to three sites in the 5' flanking region of the rat somatostatin gene and transactivates somatostatin promoter-reporter constructs; mutation of IDX-1 binding sites attenuates transactivation, identifying somatostatin as a direct transcriptional target.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), co-transfection reporter assay with promoter mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding assay combined with mutagenesis and reporter assay, foundational paper replicated by subsequent studies\",\n      \"pmids\": [\"7907546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"PDX-1 binds to a conserved TAAT motif (GLUT2TAAT) in the murine and human GLUT2 promoter and transactivates GLUT2 gene expression; mutation of the GLUT2TAAT motif reduces promoter activity by 41%, and PDX-1 activates a heterologous promoter containing multimerized GLUT2TAAT only in PDX-1-expressing cell lines.\",\n      \"method\": \"EMSA, co-transfection reporter assay with promoter mutants, supershift with PDX-1 antiserum\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct binding demonstrated by EMSA with antibody supershift, functional consequence confirmed by mutagenesis and reporter assay\",\n      \"pmids\": [\"8923459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"STF-1/PDX-1 binds cooperatively with Pbx (mammalian homolog of extradenticle) to DNA; cooperative binding requires the pentapeptide FPWMK motif and the N-terminal arm of the STF-1 homeodomain. Cooperative binding occurs only on a subset of potential STF-1 target sites, suggesting Pbx specifies target gene selection.\",\n      \"method\": \"EMSA with recombinant proteins and mutagenesis of FPWMK motif and homeodomain\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted cooperative DNA binding in vitro with domain mutagenesis identifying key residues\",\n      \"pmids\": [\"8524276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"STF-1 (PDX1) islet-specific expression requires two elements: a distal enhancer (-3 to -6.5 kb) and a proximal E-box at -104 bound by the helix-loop-helix/leucine zipper factor USF; point mutation disrupting USF binding impairs STF-1 promoter activity in transgenic mice.\",\n      \"method\": \"Transgenic reporter assay, mutagenesis, EMSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis validated in transgenic mice combined with direct binding assay\",\n      \"pmids\": [\"8567692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"An islet-specific enhancer directing STF-1 (PDX1) expression is regulated by HNF-3beta and BETA-2 binding elements; glucocorticoids repress STF-1 gene expression by interfering with HNF-3beta activity on this enhancer, and overexpression of HNF-3beta suppresses glucocorticoid receptor-mediated inhibition.\",\n      \"method\": \"Reporter assay, overexpression, glucocorticoid receptor inhibition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assay with overexpression, single lab with two orthogonal approaches\",\n      \"pmids\": [\"9111329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Domain mapping of IDX-1 (PDX1) identifies: the homeodomain mediates sequence-specific DNA binding (substitution mutations abolish binding); the N-terminal transactivation domain is required for somatostatin promoter transactivation; C-terminal regions mediate protein-protein interactions that synergistically enhance transactivation; nuclear localization signals reside within the homeodomain.\",\n      \"method\": \"N- and C-terminal deletion and point-substitution mutagenesis, EMSA, reporter assay, nuclear extract fractionation\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis with multiple orthogonal methods (DNA binding, nuclear localization, reporter assay) in one study\",\n      \"pmids\": [\"8770920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Exposure of isolated rat pancreatic islets to palmitic acid causes ~70% decrease in IDX-1 mRNA and protein and 40-65% decreases in IDX-1 binding activity at Glut2 and insulin promoter elements, correlating with decreases in GLUT2, glucokinase, insulin, and somatostatin expression; this effect requires mitochondrial oxidation of palmitate (prevented by carnitine palmitoyltransferase I inhibitor).\",\n      \"method\": \"Western blot, EMSA, RT-PCR, pharmacological inhibition of mitochondrial fatty acid oxidation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (protein, mRNA, DNA binding activity) replicated in primary islets with mechanistic inhibitor\",\n      \"pmids\": [\"9374511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"STF-1/PDX-1 expression decreases rapidly and reversibly in INS-1 cells exposed to elevated glucose (>8 mM); the decrease in STF-1 binding activity correlates with decreased STF-1 mRNA occurring independently of changes in STF-1 promoter activity, suggesting posttranscriptional regulation; associated insulin gene promoter activity decreases are partially reversed by lowering glucose.\",\n      \"method\": \"Transient transfection reporter assay, EMSA, Northern blot, RT-PCR\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (reporter assay, EMSA, mRNA levels) in single lab\",\n      \"pmids\": [\"9482663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Misexpressed IDX-1 (PDX1) binds to and inhibits transactivation of the sucrase-isomaltase promoter by the gut homeodomain protein Cdx-2, providing a mechanism for the dysmorphogenesis of the proximal colon observed in Hoxa-4/IDX-1 transgenic mice.\",\n      \"method\": \"Transgenic mouse model, reporter assay, protein-protein interaction analysis\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional interaction between PDX-1 and Cdx-2 demonstrated by reporter assay and binding analysis in transgenic model\",\n      \"pmids\": [\"9679043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PDX-1 directly binds to the GIP gene promoter regulatory region in intact cells and nuclear extracts, and overexpression of PDX-1 in transfection assays increases GIP/luciferase reporter activity; PDX-1 null mice show 97.8% reduction in GIP-expressing cells, establishing PDX-1 as a direct regulator of cell-specific GIP expression.\",\n      \"method\": \"EMSA, chromatin immunoprecipitation (ChIP), transient transfection reporter assay, PDX-1 null mouse analysis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct chromatin occupancy by ChIP confirmed in intact cells, combined with null mouse phenotype and reporter assay\",\n      \"pmids\": [\"15486225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PCIF1 (a POZ domain protein) interacts with the C-terminus of PDX-1 both in vitro and in vivo; coexpression of PDX-1 alters subnuclear distribution of PCIF1; PCIF1 inhibits PDX-1 transactivation of target gene promoters in a dose-dependent manner requiring critical amino acids in the PDX-1 C-terminus; PCIF1 is expressed in beta cells and represses the insulin promoters.\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, reporter assay, mutagenesis, immunofluorescence\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro binding plus in vivo co-IP plus functional reporter assay with mutagenesis in single study\",\n      \"pmids\": [\"15121856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Bridge-1 (PDZ-domain coactivator) directly interacts with the amino-terminal transactivation domain of PDX-1 in GST pulldown assays and in yeast two-hybrid; Bridge-1 increases PDX-1 transactivation of somatostatin and insulin promoters, including synergistic activation of the rat insulin I promoter FarFlat enhancer together with E12 and E47.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, reporter assay with Gal4 fusion proteins\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction confirmed by GST pulldown and yeast two-hybrid, functional consequence shown by reporter assay; single lab\",\n      \"pmids\": [\"15885879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Dominant-negative PDX-1 (DN-Pdx-1) in INS-1 cells causes defective glucose-stimulated and K+-depolarization-induced insulin secretion; DN-Pdx-1 downregulates FGFR1 and consequently prohormone convertases PC-1/3 and PC-2, severely impairing proinsulin processing; PDX-1 also regulates GLP-1 receptor expression, with DN-Pdx-1 reducing GLP-1R expression and cellular cAMP.\",\n      \"method\": \"Inducible dominant-negative cell lines, HPLC for insulin processing, patch-clamp capacitance, aequorin Ca2+ measurement, gene expression analysis\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal methods including electrophysiology, biochemical processing assay, and gene expression in inducible system\",\n      \"pmids\": [\"15756539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KLF11 (MODY7) regulates PDX-1 transcription in beta cells through two conserved GC-rich motifs (GC1 and GC2) in the Area II enhancer; KLF11 specifically associates with Area II by ChIP; KLF11 interacts with the coactivator p300 via its zinc finger domain in vivo to mediate PDX-1 activation.\",\n      \"method\": \"Reporter assay, ChIP, co-immunoprecipitation, random oligonucleotide binding analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — chromatin occupancy by ChIP, direct protein interaction by co-IP, and functional reporter assay with mutagenesis in single study\",\n      \"pmids\": [\"19843526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pdx1 regulates a broad array of genes involved in ER function (disulfide bond formation, protein folding, unfolded protein response) as identified by high-throughput expression microarray and chromatin occupancy analyses; Pdx1 deficiency leads to ER stress and enhanced beta cell susceptibility to ER stress-associated apoptosis.\",\n      \"method\": \"Expression microarray, chromatin occupancy (ChIP) analysis, high-fat diet mouse model, Min6 cell knockdown\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chromatin occupancy identifies direct targets, combined with loss-of-function phenotype and microarray; multiple orthogonal methods\",\n      \"pmids\": [\"19855005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Protein kinase CK2 phosphorylates Pdx-1 at amino acids Thr231 and Ser232; this phosphorylation regulates Pdx-1 transcription factor activity as measured by insulin promoter reporter assay; inhibition of CK2 by specific inhibitors leads to elevated insulin release from beta cells.\",\n      \"method\": \"In vitro kinase assay with Pdx-1 fragments and phosphorylation mutants, reporter assay, CK2 inhibitor treatment\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct in vitro phosphorylation mapping with mutagenesis, single lab\",\n      \"pmids\": [\"20339896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RB (retinoblastoma protein) associates with and stabilizes Pdx-1; Pdx-1 utilizes a conserved RB-interaction motif (RIM) also present in E2Fs; point mutations within the RIM reduce RB-Pdx-1 complex formation and promote Pdx-1 proteasomal degradation; glucose regulates RB/Pdx-1 complex formation and Pdx-1 stability; RB occupies promoters of beta-cell-specific genes.\",\n      \"method\": \"Co-immunoprecipitation, point mutagenesis, proteasome inhibitor assays, ChIP, RB knockdown, in vivo RB-deficient mice\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (co-IP, mutagenesis, ChIP, in vivo knockout), glucose-dependent regulation of complex\",\n      \"pmids\": [\"21399612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Global Pdx1 chromatin occupancy analysis in mouse and human pancreatic islets by ChIP-seq identifies conserved target genes enriched for endocrine/metabolic functions; the conserved cistrome provides molecular explanation for Pdx1-deficiency phenotypes.\",\n      \"method\": \"ChIP-seq in mouse and human islets\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-scale direct chromatin occupancy in both human and mouse islets, replicated across species\",\n      \"pmids\": [\"22322596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SIRT1 forms a protein complex with FOXA2 and other proteins on the Pdx1 gene promoter; SIRT1 deacetylates FOXA2 on the Pdx1 promoter and positively regulates Pdx1 transcription; pancreas-specific disruption of SIRT1 diminishes PDX1 expression and impairs islet development.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, pancreas-specific Sirt1 knockout mice, deacetylation assay\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and ChIP establish complex formation and occupancy; in vivo knockout validates functional consequence; single lab\",\n      \"pmids\": [\"24163589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Beta-cell-specific deletion of Pdx1 in adult mice causes rapid acquisition of alpha-cell ultrastructural and physiological features, including derepression of the alpha-cell transcription factor MafB; Pdx1 thus simultaneously activates beta-cell identity genes and represses alpha-cell identity genes, functioning as a master regulator of beta-cell fate.\",\n      \"method\": \"Conditional beta-cell-specific Pdx1 deletion, lineage tracing, transcriptomic profiling, electron microscopy, functional assays\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with fate mapping, transcriptomics, and multiple functional readouts; replicated across multiple analyses\",\n      \"pmids\": [\"24506867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pdx1 regulates mitophagy in beta cells by controlling expression of Clec16a (itself a regulator of mitophagy through E3 ubiquitin ligase Nrdp1); loss of Pdx1 reduces Clec16a and Nrdp1 expression and impairs autophagosome-lysosome fusion during mitophagy; restoration of Clec16a after Pdx1 loss rescues mitochondrial trafficking, respiration, and glucose-stimulated insulin release.\",\n      \"method\": \"Expression microarray, ChIP, conditional Pdx1 haploinsufficiency, Clec16a rescue experiments, mitophagy flux assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — chromatin occupancy identifies Clec16a as direct target; pathway placement confirmed by rescue experiment; multiple orthogonal methods\",\n      \"pmids\": [\"26085571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pdx1 directly binds and activates E-cadherin (E-cad/Cdh1) transcription through two conserved Pdx1 binding sites in the E-cad promoter; Pdx1 is required in vivo for maintenance of E-cad expression, actomyosin complex activity, and cell shape during pancreatic epithelial tubulogenesis and ductal plexus formation.\",\n      \"method\": \"ChIP, reporter assay, Pdx1-/- mouse embryo analysis, promoter mutagenesis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct binding by ChIP with promoter mutagenesis, functional consequence demonstrated in vivo\",\n      \"pmids\": [\"26657766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HMGA1 physically interacts with PDX-1 and MafA both in vitro and in vivo; HMGA1 overexpression enhances PDX-1 and MafA transactivation of human and mouse insulin promoters; HMGA1 knockdown decreases this transactivating activity; high glucose increases HMGA1 binding to the insulin promoter.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, reporter assay, ChIP, siRNA knockdown\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction by co-IP and GST pulldown, functional consequence by reporter assay and ChIP; single lab\",\n      \"pmids\": [\"25628604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PDX1 forms a stress-inducible complex with ATF4 and ATF5; PDX1 occupies CARE (C/EBP-ATF) composite motifs at 26 genes involved in stress/apoptosis including Gpt2, Chac1, and Slc7a1; co-enrichment of ATF4 and ATF5 at these sites was confirmed by ChIP; deficiency of Gpt2 reduces beta-cell susceptibility to stress-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, RNAseq, gRNA/shRNA silencing, caspase-3 activation assay\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-scale ChIP-seq with co-IP and RNA-seq, functional validation by genetic silencing with defined apoptotic readout\",\n      \"pmids\": [\"30174228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ChIP-seq of PDX1 in human iPSC-derived pancreatic progenitors identifies 8,088 binding regions mapping to 5,664 genes, including PDX1 auto-regulatory feedback on its own promoter, RFX6, HNF1B, MEIS1, RFX3, and DLL1; stage-specific comparison with adult islet PDX1 profiles reveals distinct developmental vs. adult target gene sets.\",\n      \"method\": \"ChIP-seq (PDX1 and H3K27ac) in iPSC-derived pancreatic progenitors vs. adult human islets, mRNA expression profiling\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-scale chromatin occupancy in two human developmental stages with active chromatin validation; comprehensive target identification\",\n      \"pmids\": [\"29396371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Missense mutations in the PDX1 transactivation domain (P33T, C18R) impair PDX1-dependent gene expression and beta-cell differentiation; homozygous and heterozygous mutations reduce differentiation efficiency of pancreatic progenitors by downregulating PDX1-bound target genes including MNX1, PDX1 itself (autoregulation), CES1, MEG3, and NNAT.\",\n      \"method\": \"iPSC-derived isogenic cell lines with CRISPR-engineered mutations, in vitro beta-cell differentiation, gene expression profiling\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — isogenic iPSC system with defined mutations in transactivation domain, multiple orthogonal readouts of target gene expression\",\n      \"pmids\": [\"30930126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Saturated fatty acids (palmitic acid) stimulate stress granule (SG) formation in beta cells via PI3K/EIF2α-dependent pathway; PDX1 and nucleocytoplasmic transport factors are sequestered in SGs, preventing nuclear localization of PDX1 and inhibiting glucose-induced insulin secretion; genetic deletion of TIA1 or pharmacological PI3K/EIF2α inhibition blocks SG formation, restores PDX1 nuclear localization, and ameliorates HFD-induced beta cell dysfunction.\",\n      \"method\": \"Immunofluorescence, mass spectrometry of SG components, nucleocytoplasmic transport reporters, TIA1 knockout mice, pharmacological inhibitors\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mass spectrometry identifies PDX1 in SGs, genetic and pharmacological rescue experiments validate mechanism, in vitro and in vivo validation\",\n      \"pmids\": [\"33569632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"OGT (O-GlcNAc transferase) deletion in beta cells reduces Pdx1 levels; Pdx1 overexpression rescues mitochondrial morphology and function, insulin content, and mitochondrial oxygen consumption in OGT-deficient islets, placing Pdx1 downstream of OGT in regulating mitochondrial biogenesis.\",\n      \"method\": \"Conditional OGT knockout, proteomics, Pdx1 overexpression rescue, mitochondrial respiration assay (Seahorse), electron microscopy\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rescue experiment establishes epistatic relationship; multiple orthogonal methods; single lab\",\n      \"pmids\": [\"34462257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PDX1 silences NF-κB at circadian and inflammatory enhancers through long-range chromatin contacts involving SIN3A; single-cell chromatin analysis identifies beta cell subtypes with high vs. low PDX1 activity, with low-PDX1 cells showing increased chromatin accessibility at latent NF-κB enhancers; Pdx1 hypomorphic mice show de-repression of NF-κB and impaired nocturnal glucose tolerance; antagonizing the IL-1β receptor (an NF-κB target) improves insulin secretion in Pdx1 hypomorphic islets.\",\n      \"method\": \"Single-cell ATAC-seq, ChIP-seq, 3D chromatin analysis, Pdx1 hypomorphic mouse model, IL-1β receptor antagonism\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-scale chromatin methods with 3D contact analysis, genetic hypomorph model, and pharmacological rescue; multiple orthogonal approaches\",\n      \"pmids\": [\"38171340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The P33T missense mutation in the PDX1/IPF1 transactivation domain reduces DNA-binding and transcriptional activation in vitro compared to wild-type IPF1, as measured by reporter gene assay.\",\n      \"method\": \"In vitro reporter gene assay with mutant IPF1 protein expression\",\n      \"journal\": \"Metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay of mutant protein; corroborated by later iPSC studies\",\n      \"pmids\": [\"16092045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IPF1/PDX1 gene transfer to isolated Psammomys obesus islets (which lack functional IPF1/PDX1 protein) normalizes the defect in glucose-stimulated insulin gene expression and prevents rapid depletion of insulin content after high glucose exposure, directly linking PDX1 to glucose-responsive insulin gene transcription.\",\n      \"method\": \"IPF1/PDX1 gene transfer into isolated islets, Western blot, DNA binding assay, RT-PCR, immunostaining\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue by gene transfer in a naturally PDX1-deficient model; multiple assays confirming mechanism\",\n      \"pmids\": [\"11473041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PDX-1 haploinsufficiency (Pdx1+/-) leads to increased beta-cell apoptosis associated with reduced Bcl-XL and Bcl-2 expression, abnormal islet architecture, active caspase-3, and failure of beta-cell mass expansion with age; glucose sensing and stimulus-secretion coupling in individual cells remain normal, indicating the organ-level insulin secretion defect is due to reduced beta-cell mass via increased apoptosis.\",\n      \"method\": \"Pdx1+/- mouse model, TUNEL, caspase-3 activation, electrophysiology, perifusion/static incubation, Western blot for Bcl-XL/Bcl-2\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple complementary methods including electrophysiology, apoptosis assays, and functional secretion studies; dissects organ- from cell-level defect\",\n      \"pmids\": [\"12697734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PDX1 chromatin occupancy shifts profoundly between acinar cells and pancreatic ductal adenocarcinoma (PDA) cells, with PDX1 performing stage-specific functions: maintaining acinar cell identity (tumor-suppressive) vs. an oncogenic role in established PDA; PDX1 loss in malignant cells is associated with epithelial-to-mesenchymal transition.\",\n      \"method\": \"ChIP-seq in acinar cells and PDA, conditional PDX1 deletion/activation mouse models, lineage tracing\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-scale ChIP-seq across cell states with in vivo genetic models; multiple orthogonal methods\",\n      \"pmids\": [\"28087712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Foxa2 and Pdx1 genetically and functionally cooperate to regulate postnatal beta-cell maturation; combined reduction of both Foxa2 and Pdx1 (in double knock-in reporter mice) causes hyperglycemia, loss of beta-cell identity, and transdifferentiation towards other endocrine cell fates, whereas reduction of either alone is insufficient.\",\n      \"method\": \"Double knock-in fluorescent reporter mouse (Foxa2-Venus; Pdx1-BFP), glucose tolerance testing, histological and transcriptional analysis\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in double knock-in model with functional phenotypic readout; single lab\",\n      \"pmids\": [\"28580283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PDX-1 protein transduction occurs by endocytosis followed by release from endosomes; PDX-1 PTD is internalized via lipid raft-dependent macropinocytosis (blocked by amiloride and cytochalasin D but not by dominant-negative dynamin-1, ruling out clathrin- or caveolar-mediated endocytosis); internalized protein transits through the Golgi complex and ER before homogeneous cytoplasmic/nuclear distribution.\",\n      \"method\": \"Live-cell fluorescence imaging of FITC-PDX1-PTD, dominant-negative dynamin-1 expression, pharmacological inhibitors (amiloride, cytochalasin D), endosomal/Golgi markers\",\n      \"journal\": \"Biochemical and biophysical research communications / Cell transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic dissection of uptake mechanism with live imaging; two concurrent papers from same group\",\n      \"pmids\": [\"15896300\", \"16405074\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDX1 is a homeodomain transcription factor that directly binds TAAT-containing regulatory elements in target gene promoters (insulin, somatostatin, GLUT2, GIP, E-cadherin, and many others) through its homeodomain, recruits coactivators (Bridge-1, HMGA1, p300 via KLF11) and forms stress-induced complexes with ATF4/ATF5 at CARE motifs, while being repressed by PCIF1; its activity is regulated post-translationally by CK2-mediated phosphorylation at Thr231/Ser232, by RB-mediated stabilization against proteasomal degradation, by nuclear sequestration in saturated-fatty-acid-induced stress granules (via PI3K/EIF2α/TIA1), and by SIRT1-mediated deacetylation of its promoter regulator FOXA2; in beta cells PDX1 simultaneously activates beta-cell identity genes and represses alpha-cell programs (including via SIN3A-mediated long-range silencing of NF-κB enhancers), regulates ER protein-folding gene networks, and controls mitophagy through Clec16a-Nrdp1, making it a master regulator of pancreatic development, beta-cell identity, and beta-cell survival.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PDX1 is a homeodomain transcription factor that serves as a master regulator of pancreatic development and beta-cell identity, required for outgrowth, proliferation, and differentiation of the pancreatic progenitor pool [#0]. Through its homeodomain it binds TAAT-containing regulatory elements to directly activate a conserved cistrome of endocrine and metabolic target genes, including somatostatin [#1], GLUT2 [#2], GIP [#10], E-cadherin [#22], and its own promoter via autoregulatory feedback [#25], with cooperative DNA binding to Pbx (mediated by the FPWMK pentapeptide motif) restricting target selection [#3]; its homeodomain mediates sequence-specific binding and nuclear localization while an N-terminal transactivation domain and C-terminal protein-interaction regions drive transactivation [#6]. Genome-scale ChIP-seq across mouse and human islets, iPSC-derived progenitors, and tumor cells establishes that PDX1 occupancy is stage- and context-specific [#18, #25, #33]. In mature beta cells PDX1 enforces beta-cell fate by simultaneously activating beta-cell identity genes and repressing the alpha-cell program, such that its deletion derepresses MafB and drives acquisition of alpha-cell features [#20]; it also silences NF-\\u03baB at inflammatory enhancers through long-range chromatin contacts involving SIN3A [#29]. Beyond identity, PDX1 controls beta-cell survival and metabolic competence by governing ER protein-folding gene networks [#15], Clec16a-Nrdp1-dependent mitophagy [#21], and glucose-stimulated insulin secretion and proinsulin processing [#13, #31]; haploinsufficiency increases beta-cell apoptosis and impairs mass expansion [#32]. PDX1 activity is tuned post-translationally by CK2 phosphorylation at Thr231/Ser232 [#16], RB-mediated stabilization against proteasomal degradation [#17], and nuclear exclusion via sequestration into saturated-fatty-acid-induced stress granules [#27], while its expression is set by upstream regulators including USF, HNF-3beta/BETA-2, KLF11, and SIRT1-deacetylated FOXA2 [#4, #5, #14, #19]. Missense mutations in its transactivation domain (P33T, C18R) impair target gene activation and beta-cell differentiation [#26, #30].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that PDX1 is a sequence-specific DNA-binding transactivator by identifying its first direct genomic target, defining its molecular identity as a transcription factor.\",\n      \"evidence\": \"EMSA and promoter-reporter mutagenesis on the rat somatostatin gene\",\n      \"pmids\": [\"7907546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address genome-wide target repertoire\", \"Promoter context only, no chromatin occupancy in vivo\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Resolved how PDX1 achieves target selectivity by showing cooperative DNA binding with Pbx requires the FPWMK motif and homeodomain N-terminal arm, restricting occupancy to a subset of sites.\",\n      \"evidence\": \"EMSA with recombinant proteins and motif/domain mutagenesis\",\n      \"pmids\": [\"8524276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro reconstitution only\", \"Which physiological targets depend on Pbx not enumerated\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstrated that PDX1 is genetically required for pancreatic development, establishing its master-regulator role beyond single-promoter regulation.\",\n      \"evidence\": \"Two independent null-allele knockout mice with histology and immunostaining\",\n      \"pmids\": [\"8631275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Knockout does not separate progenitor proliferation from differentiation defects mechanistically\", \"Direct target genes responsible for agenesis not defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapped PDX1 functional domains, assigning DNA binding and nuclear localization to the homeodomain and transactivation to the N-terminus, providing a structure-function framework.\",\n      \"evidence\": \"Deletion/point mutagenesis with EMSA, reporter assay, and nuclear fractionation\",\n      \"pmids\": [\"8770920\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the domains\", \"Identity of C-terminal interaction partners not yet known\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Extended the direct target set to GLUT2, linking PDX1 to beta-cell glucose-sensing gene expression.\",\n      \"evidence\": \"EMSA with antibody supershift, reporter mutagenesis of the GLUT2TAAT motif\",\n      \"pmids\": [\"8923459\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residual promoter activity after motif mutation indicates other inputs\", \"In vivo occupancy not shown in this study\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined the upstream regulatory architecture of the PDX1 gene itself, identifying a distal enhancer and proximal USF-bound E-box required for islet-specific expression.\",\n      \"evidence\": \"Transgenic reporter assays, mutagenesis, EMSA\",\n      \"pmids\": [\"8567692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full enhancer composition not exhaustively mapped\", \"Does not address dynamic regulation\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Connected PDX1 expression to hormonal and metabolic signals, showing HNF-3beta/BETA-2 control of its enhancer and glucocorticoid repression.\",\n      \"evidence\": \"Reporter assays with overexpression and GR-mediated inhibition\",\n      \"pmids\": [\"9111329\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab reporter-based mechanism\", \"No in vivo glucocorticoid validation\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identified lipotoxic suppression of PDX1, showing palmitate lowers PDX1 expression and DNA-binding via mitochondrial fatty-acid oxidation, linking PDX1 to beta-cell metabolic stress.\",\n      \"evidence\": \"Western blot, EMSA, RT-PCR with CPT-I inhibitor in primary rat islets\",\n      \"pmids\": [\"9374511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the molecular signal connecting oxidation to PDX1 loss\", \"Distinguishing transcriptional vs post-transcriptional control incomplete\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed PDX1 is dynamically and reversibly downregulated by elevated glucose through a post-transcriptional mechanism, indicating rapid environmental tuning of its abundance.\",\n      \"evidence\": \"Reporter assay, EMSA, Northern/RT-PCR in INS-1 cells\",\n      \"pmids\": [\"9482663\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Post-transcriptional mechanism not molecularly defined\", \"Single cell-line context\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Revealed PDX1 can act as a transcriptional antagonist of another homeodomain factor (Cdx-2), explaining gut dysmorphogenesis on ectopic expression.\",\n      \"evidence\": \"Transgenic mouse, reporter assay, protein-interaction analysis\",\n      \"pmids\": [\"9679043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of inhibition (binding vs squelching) not fully resolved\", \"Ectopic-expression context limits physiological relevance\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Provided causal rescue evidence that PDX1 drives glucose-responsive insulin gene transcription, by restoring function in a naturally PDX1-deficient islet model.\",\n      \"evidence\": \"IPF1/PDX1 gene transfer into Psammomys obesus islets with DNA binding and expression assays\",\n      \"pmids\": [\"11473041\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression rescue may not mirror endogenous stoichiometry\", \"Single model system\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Distinguished organ-level from cell-level secretion defects, showing PDX1 haploinsufficiency reduces beta-cell mass through increased apoptosis rather than impairing single-cell glucose sensing.\",\n      \"evidence\": \"Pdx1+/- mice with TUNEL, caspase-3, electrophysiology, perifusion, Bcl-XL/Bcl-2 Western\",\n      \"pmids\": [\"12697734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PDX1 targets controlling survival genes not defined here\", \"Mechanism linking PDX1 dose to apoptosis incomplete\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified PCIF1 as a direct C-terminal-binding repressor of PDX1, defining a negative regulator of its transactivation in beta cells.\",\n      \"evidence\": \"GST pulldown, co-IP, reporter assay, mutagenesis, immunofluorescence\",\n      \"pmids\": [\"15121856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo physiological role of PCIF1 repression not established\", \"Single study\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Confirmed direct in-cell chromatin occupancy of PDX1 at the GIP promoter, extending PDX1 control to enteroendocrine cell-specific gene expression.\",\n      \"evidence\": \"ChIP, EMSA, reporter assay, and GIP cell quantification in PDX-1 null mice\",\n      \"pmids\": [\"15486225\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors at the GIP promoter not identified\", \"Tissue-specificity determinants unaddressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified Bridge-1 as a coactivator binding the PDX1 transactivation domain, beginning to define the coactivator network amplifying PDX1 output.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, reporter assays with Gal4 fusions\",\n      \"pmids\": [\"15885879\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo validation\", \"Single-lab interaction data\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the consequences of disrupting PDX1 function on insulin biology, showing it controls proinsulin processing (via FGFR1/PC1/3/PC2) and incretin signaling (GLP-1R), broadening its role beyond transcription of insulin itself.\",\n      \"evidence\": \"Inducible dominant-negative INS-1 cells with HPLC processing, patch-clamp, Ca2+ measurement, expression analysis\",\n      \"pmids\": [\"15756539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dominant-negative may affect non-physiological targets\", \"Direct vs indirect regulation of each gene not fully parsed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"First functional characterization of a disease-associated PDX1 mutation, showing P33T impairs DNA binding and transactivation.\",\n      \"evidence\": \"In vitro reporter assay with mutant IPF1 protein\",\n      \"pmids\": [\"16092045\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro only; cellular and developmental consequences addressed later\", \"Single mutation\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Characterized the cellular uptake route of exogenous PDX1 protein transduction domain, relevant to its use as a delivered reprogramming factor.\",\n      \"evidence\": \"Live-cell imaging, dominant-negative dynamin, pharmacological inhibitors, organelle markers\",\n      \"pmids\": [\"15896300\", \"16405074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Describes engineered transduction, not endogenous PDX1 trafficking\", \"Two papers from same group\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established the regulatory circuit setting PDX1 levels, showing KLF11 activates the PDX1 Area II enhancer through GC motifs and recruits p300.\",\n      \"evidence\": \"Reporter assay, ChIP, co-IP, oligonucleotide binding analysis\",\n      \"pmids\": [\"19843526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo requirement of KLF11 for PDX1 expression not shown here\", \"Single study\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked PDX1 to beta-cell survival mechanistically by showing it directly regulates ER protein-folding gene networks, with deficiency causing ER stress and apoptosis susceptibility.\",\n      \"evidence\": \"Expression microarray, ChIP occupancy, high-fat diet model, Min6 knockdown\",\n      \"pmids\": [\"19855005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual critical ER targets not pinpointed\", \"Direct vs secondary effects within the network unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified CK2 phosphorylation of PDX1 at Thr231/Ser232 as a post-translational modulator of its transcriptional activity and insulin release.\",\n      \"evidence\": \"In vitro kinase assay with phosphomutants, reporter assay, CK2 inhibitor treatment\",\n      \"pmids\": [\"20339896\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo phosphorylation state not quantified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined glucose-regulated PDX1 protein stability, showing RB binds a conserved RIM motif to protect PDX1 from proteasomal degradation.\",\n      \"evidence\": \"Co-IP, point mutagenesis, proteasome inhibition, ChIP, RB knockdown, RB-deficient mice\",\n      \"pmids\": [\"21399612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase targeting PDX1 not identified\", \"How glucose signals to the complex unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the conserved PDX1 cistrome across mouse and human islets, providing genome-scale molecular explanation for deficiency phenotypes.\",\n      \"evidence\": \"ChIP-seq in mouse and human islets\",\n      \"pmids\": [\"22322596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Occupancy does not establish functional dependence for each gene\", \"Cell-type heterogeneity within islets not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed SIRT1 upstream of PDX1, showing SIRT1 deacetylates FOXA2 on the PDX1 promoter to positively control its transcription and islet development.\",\n      \"evidence\": \"Co-IP, ChIP, pancreas-specific Sirt1 knockout, deacetylation assay\",\n      \"pmids\": [\"24163589\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect SIRT1 effects on FOXA2 acetylation in vivo\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established PDX1 as an active enforcer of beta-cell identity that represses the alpha-cell program, since its loss in adult beta cells triggers acquisition of alpha-cell features and MafB derepression.\",\n      \"evidence\": \"Conditional beta-cell Pdx1 deletion with lineage tracing, transcriptomics, EM, functional assays\",\n      \"pmids\": [\"24506867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of alpha-gene repression not yet molecular in this study\", \"Reversibility of identity loss unaddressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a developmental morphogenesis function, showing PDX1 directly activates E-cadherin to maintain epithelial cell shape during pancreatic tubulogenesis.\",\n      \"evidence\": \"ChIP, reporter assay, promoter mutagenesis, Pdx1-/- embryo analysis\",\n      \"pmids\": [\"26657766\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Link between E-cadherin loss and overall ductal phenotype partly correlative\", \"Other adhesion targets not surveyed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected PDX1 to organelle quality control, showing it directly controls Clec16a-Nrdp1-dependent mitophagy required for beta-cell respiration and insulin secretion.\",\n      \"evidence\": \"Microarray, ChIP, conditional haploinsufficiency, Clec16a rescue, mitophagy flux assays\",\n      \"pmids\": [\"26085571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mitophagy defect alone accounts for secretion loss not isolated\", \"Other autophagy targets not examined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Added HMGA1 as a glucose-responsive coactivator enhancing PDX1/MafA transactivation of the insulin promoter.\",\n      \"evidence\": \"Co-IP, GST pulldown, reporter assay, ChIP, siRNA\",\n      \"pmids\": [\"25628604\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo validation\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed context-dependent, even opposing, PDX1 functions, showing its cistrome and role shift from acinar identity maintenance (tumor-suppressive) to oncogenic in pancreatic ductal adenocarcinoma.\",\n      \"evidence\": \"ChIP-seq in acinar and PDA cells, conditional deletion/activation mouse models, lineage tracing\",\n      \"pmids\": [\"28087712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of the cistrome switch not defined\", \"Cofactors driving oncogenic redirection unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated genetic cooperation between PDX1 and FOXA2 in postnatal beta-cell maturation, showing combined dose reduction—but not either alone—causes identity loss and transdifferentiation.\",\n      \"evidence\": \"Double knock-in reporter mice, glucose tolerance testing, histology and transcriptional analysis\",\n      \"pmids\": [\"28580283\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Shared vs distinct target genes not fully resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified a stress-inducible mode of PDX1 action, showing it forms complexes with ATF4/ATF5 at CARE motifs to regulate stress/apoptosis genes such that Gpt2 loss reduces apoptotic susceptibility.\",\n      \"evidence\": \"Co-IP, ChIP-seq, RNA-seq, genetic silencing, caspase-3 assay\",\n      \"pmids\": [\"30174228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger conditions for complex assembly not fully defined\", \"Direction of PDX1 effect (pro- vs anti-apoptotic) context-dependent\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the developmental PDX1 cistrome in human iPSC-derived progenitors, revealing autoregulation and stage-specific targets distinct from adult islets.\",\n      \"evidence\": \"ChIP-seq (PDX1, H3K27ac) in iPSC progenitors vs adult islets with expression profiling\",\n      \"pmids\": [\"29396371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional dependence of each developmental target not tested\", \"iPSC progenitors may not fully recapitulate in vivo development\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided causal disease-relevant evidence that transactivation-domain mutations (P33T, C18R) impair PDX1 target activation and beta-cell differentiation in an isogenic human system.\",\n      \"evidence\": \"CRISPR-engineered isogenic iPSC lines, in vitro beta-cell differentiation, expression profiling\",\n      \"pmids\": [\"30930126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of transactivation-domain loss at molecular level not detailed\", \"Patient-level phenotype correlation outside scope\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified a non-transcriptional regulatory layer, showing saturated fatty acids sequester PDX1 in stress granules via PI3K/EIF2\\u03b1/TIA1, blocking its nuclear localization and insulin secretion.\",\n      \"evidence\": \"Immunofluorescence, mass spectrometry of SG components, transport reporters, TIA1 knockout mice, inhibitors\",\n      \"pmids\": [\"33569632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PDX1 is selectively recruited to stress granules unknown\", \"Reversibility kinetics in vivo not fully quantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed PDX1 downstream of OGT in mitochondrial regulation, showing PDX1 re-expression rescues mitochondrial function in OGT-deficient beta cells.\",\n      \"evidence\": \"Conditional OGT knockout, proteomics, Pdx1 overexpression rescue, Seahorse respiration, EM\",\n      \"pmids\": [\"34462257\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether OGT acts on PDX1 directly or via its expression unresolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a long-range repressive mechanism, showing PDX1 silences NF-\\u03baB at inflammatory/circadian enhancers via SIN3A-mediated chromatin contacts, with low-PDX1 beta cells showing NF-\\u03baB derepression rescuable by IL-1\\u03b2 receptor antagonism.\",\n      \"evidence\": \"Single-cell ATAC-seq, ChIP-seq, 3D chromatin analysis, Pdx1 hypomorphic mice, IL-1\\u03b2R antagonism\",\n      \"pmids\": [\"38171340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PDX1 directs SIN3A to specific enhancers not detailed\", \"Causal link between subtype heterogeneity and disease not fully established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the diverse upstream inputs (CK2, RB, OGT, stress granules) are integrated to set PDX1 dose and activity in vivo, and what determines the context-specific cistrome switches between development, mature beta cells, and tumor states.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating transcriptional, post-translational, and localization control\", \"Determinants of context-dependent target selection unknown\", \"Cofactor requirements for repressive vs activating modes not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 6, 10, 18, 20, 22, 24, 25, 29]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 2, 3, 6, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 27]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [18, 25, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 2, 10, 18, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 20, 22, 26]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [15, 24, 27]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [24, 32]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PBX1\", \"PCIF1\", \"RB1\", \"KLF11\", \"HMGA1\", \"ATF4\", \"ATF5\", \"SIN3A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}